Taigen Biopharmaceuticals Holdings Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Taigen Biopharmaceuticals Holdings Ltd

Watchlist Manager

Watchlist

Price: 8.77 TWD 1.04%

Market Cap: NT$6.2B

T	Taigen Biopharmaceuticals Holdings Ltd TPEX:4157	TW
	Kenedix Residential Next Investment Corp F:91K	JP
	Zhaoheng Hydropower Co Ltd OTC:ZHYLF	HK
	Mapfre SA MAD:MAP	ES
K	Kolon Global Corp KRX:003075	KR
	Zeder Investments Ltd F:33Z	ZA
R	Remy Cointreau SA XMUN:RMC	FR
	Presidio Property Trust Inc NASDAQ:SQFT	US

Profitability Summary

Taigen Biopharmaceuticals Holdings Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

93%

Strong 3Y Average Gross Margin

84%

Gross Margin is Increasing

93% > 93%

Healthy Operating Margin

29%

Negative 3Y Average Operating Margin

-150%

Operating Margin is Increasing

-103% > 29%

Healthy Net Margin

21%

Negative 3Y Average Net Margin

-64%

Net Margin is Increasing

-110% > 21%

Exceptional Free Cash Flow Margin

17%

Negative 3Y Average Free Cash Flow Margin

-31%

Free Cash Flow Margin is Increasing

Negative 3Y Average ROIC

-68%

ROIC is Increasing

-77% > 38%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.